- Recent Funding
- Investors
- Jefferson Life Sciences
Jefferson Life Sciences portfolio
Jefferson Life Sciences has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months. Its most recent investment on record is Draig Therapeutics's $65M Series B+ round in July 2026, alongside Marshall Wace, Janus Henderson Investors, Deep Track Capital and 1 other. That company is in Health and bio.
What Jefferson Life Sciences invests in
- Health and bio · 1 · 100%
How Jefferson Life Sciences invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $65M |
Share is of the 1 round on Recent Funding that name Jefferson Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Jefferson Life Sciences portfolio companies
DDraig Therapeutics$65MSeries B+ · Jul 2026
| Company | Round with Jefferson Life Sciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $65M | $205M | Jul 14, 2026 Series B+ |
Most frequent co-investors
MMarshall Wace1 shared round · last Jul 14, 2026
JJanus Henderson Investors1 shared round · last Jul 14, 2026
DDeep Track Capital1 shared round · last Jul 14, 2026
BBritish Business Bank1 shared round · last Jul 14, 2026
Similar investors
AAccelia Capital1 company · 1 deal in 12 mo
AAngel Academe1 company · 1 deal in 12 mo
BBioGenerator Ventures1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moDDeepWork Capital1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
Portfolio companies are the companies on Recent Funding with a round that lists Jefferson Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/jefferson-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.